Day One Biopharmaceuticals, Inc.DAWNNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank48
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
-13.22%
↑ 53% vs avg
Percentile
P48
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-28.02%
Historical baseline
PeriodValue
Q4 2025-13.22%
Q3 202530.66%
Q2 202514.84%
Q1 202537.14%
Q4 2024-320.45%
Q3 2024125.81%
Q2 2024-71.95%
Q1 2024-12.18%
Q4 2023-15.71%
Q3 2023-4.43%
Q2 2023-7.41%
Q1 2023-7.28%
Q4 2022-7.67%
Q3 2022-8.12%
Q2 2022-32.33%
Q1 2022-26.27%
Q4 2021-14.21%
Q3 2021-24.63%
Q2 20214.02%
Q1 2021-161.82%
Q4 2020-72.54%
Q3 2020-54.22%
Q2 2020-30.53%
Q1 20200.00%